Posted on 10/22/18
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity . . .
Posted on 10/19/18
Natera and Neon Therapeutics Announce Clinical Trial Collaboration
SAN CARLOS, Calif. and CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, and Neon Therapeutics, . . .
Posted on 10/18/18
CareCentrix Earns URAC Accreditation in Health Utilization Management
CareCentrix is proud to announce that it has earned URAC accreditation in Health Utilization Management. URAC is the independent leader in promoting healthcare quality through accreditation, . . .
Posted on 10/18/18
4G Clinical Named One of the 2018 Best Small & Medium Workplaces by Great Place to Work and FORTUNE
Great Place to Work and FORTUNE have honored 4G Clinical as one of the 2018 Best Small & Medium Workplaces. The ranking considered more than 112,000 . . .
Posted on 10/18/18
NeuroBo Pharmaceuticals Announces the Clinical Advancement of Novel Therapies
BOSTON--(BUSINESS WIRE)--NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company developing proprietary natural product-based therapeutics for neurodegenerative complications originally developed by Dong-A ST, a major Korean pharmaceutical company, . . .
Posted on 10/17/18
Partners HealthCare Launches New Center of Excellence
Today at the 10th annual Connected Health Conference, Partners HealthCare announced the formation of a new center of excellence – Partners HealthCare Pivot Labs – that . . .
Posted on 10/17/18
Clinical Laserthermia Systems Signs Distribution Agreement with MRI Interventions for USA and Canada
FRAMINGHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CLS AB (NASDAQ FIRST NORTH: CLS B) in Lund, Sweden, with the subsidiary Clinical Laserthermia Systems Americas, Inc. . . .
Posted on 10/17/18
Cue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine
CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to . . .
Posted on 10/17/18
Validic Announces Partnership With DexCom
Validic, the leading platform for patient-generated health data integration and analysis, today announced a partnership with DexCom, Inc., a leader in continuous glucose monitoring (CGM). Through . . .
Posted on 10/17/18
Foundation Medicine Announces Strategic Collaboration with Major Pharmaceutical Company
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced a strategic collaboration with Novartis allowing the development of companion diagnostic (CDx) tests for the Novartis portfolio of targeted . . .
Posted on 10/17/18
Neon Therapeutics Is An Emerging Player In Personalized Immunotherapy With Catalysts Ahead
SummaryNeon Therapeutics is a clinical-stage biotechnology company focused on leveraging neoantigen technology to provide patients with personalized immunotherapies for cancer treatment.Neon has come down substantially since . . .
Posted on 10/17/18
Ocular Therapeutix: Critical FDA Date Up Ahead
SummaryToday, we look at Ocular Therapeutix that has a critical FDA decision date fast approaching.The stock is far below its IPO debut price of a few . . .
Posted on 10/16/18
VRHealth Provides First Virtual Reality Medical Platform For Healthcare Facilities in the European Union
VRHealth, the healthcare technology company providing specialized virtual reality (VR) technology solutions and data analysis, today announced that they will provide the first virtual reality medical . . .
Posted on 10/16/18
Avant-garde Health and Gundersen Health System Partner
Avant-garde Health, an award-winning provider of actionable insights for hospitals and health systems to improve the value of care, partnered with Gundersen Health System in La . . .
Posted on 10/16/18
Charles River Laboratories Awarded Five-Year, $95.7 Million Contract
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it was awarded a five-year, $95.7 million contract by the National Institute of Allergy . . .
Posted on 10/16/18
TripleCare and Covenant Health Join to Transform Elder Care Through Telemedicine Technology
NEW YORK & TEWKSBURY, Mass.--(BUSINESS WIRE)--TripleCare, a national provider of telemedicine-based healthcare to the post-acute care sector, including skilled nursing facilities (SNFs), and Covenant Health, a . . .
Posted on 10/15/18
Great Point Partners-backed Citra Acquires DataWing
Citra Health Solutions announced today the acquisition of DataWing Software, a Portland, Oregon company specializing in administrative solutions designed to improve efficiencies
Posted on 10/15/18
SQZ Biotech Expands Cell Therapy Partnership with Roche
SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the expansion of its collaboration with Roche (SIX: RO, ROG; . . .
Posted on 10/15/18
HiFiBiO Therapeutics Acquires H-Immune Therapeutics
HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the acquisition of H-Immune Therapeutics
Posted on 10/15/18
Sarepta and Lysogene Announce Exclusive License Agreement for LYS-SAF302
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, announced today it has signed a license agreement with . . .
Posted on 10/15/18
Anthem Blue Cross and Blue Shield Will Offer Medicare Advantage Plans in 13 Maine Counties for 2019
SOUTH PORTLAND, Maine--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Maine (Anthem) will be offering up to four Medicare Advantage health plans in 13 counties in . . .
Posted on 10/14/18
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to three new employees for an . . .
Posted on 10/14/18
Ziopharm and Precigen Redefine Relationships, Announce New License Agreement
BOSTON and GERMANTOWN, Md., (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) and Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (Nasdaq: XON), today announced a . . .
Posted on 10/14/18
Sarepta Therapeutics Enters into Strategic Manufacturing Partnership with Paragon Bioservices
CAMBRIDGE, Mass., (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare . . .
Posted on 10/12/18
Here's Why Momenta Pharmaceuticals Fell 11.3% on Thursday
What happenedShares of Momenta Pharmaceuticals (NASDAQ:MNTA) fell 11.3% on Thursday, after the company presented data on its drug pipeline at the biotech's R&D day.So whatMomenta Pharmaceuticals . . .

